Literature DB >> 11996963

Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies.

Luís Belo1, Muriel Caslake, Dairena Gaffney, Alice Santos-Silva, Luís Pereira-Leite, Alexandre Quintanilha, Irene Rebelo.   

Abstract

The aim of this study was to evaluate changes in lipids, apolipoproteins and lipoproteins in Portuguese pregnant women and their potential involvement in the pathophysiology of preeclampsia. A cross-sectional study was performed by collecting blood samples in the first (n=64), second (n=48) and third (n=67) trimesters and puerperium (n=32) of normal pregnancies. Samples from preeclamptic women were obtained in the third trimester (n=51) and in puerperium (n=26). As normal pregnancy progressed and triglyceride (TG) levels rose there was a decrease in low density lipoprotein (LDL) size, as measured by peak and mean particle diameter (MPD), with an increased proportion of atherogenic small dense LDL. Preeclamptic women exhibited, in the third trimester and puerperium, higher mean serum TG concentration and lower high density lipoprotein (HDL) cholesterol and apolipoprotein A-I (apo A-I) levels compared with healthy pregnant women. In the third trimester, LDL-mean particle diameter (LDL-MPD) and LDL cholesterol-apolipoprotein B (LDLc-apo B) ratio were also significantly reduced in the pathologic group. We conclude that human gestation is associated with an 'atherogenic' lipid profile that is further enhanced in preeclampsia and that this profile may be a potential contributor to endothelial cell dysfunction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11996963     DOI: 10.1016/s0021-9150(01)00734-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  34 in total

1.  Impaired function of cerebral parenchymal arterioles in experimental preeclampsia.

Authors:  Abbie C Johnson; Marilyn J Cipolla
Journal:  Microvasc Res       Date:  2018-04-26       Impact factor: 3.514

2.  Different morphological and gene expression profile in placentas of the same sickle cell anemia patient in pregnancies of opposite outcomes.

Authors:  Letícia C Baptista; Camilla O Figueira; Bruno B Souza; Kleber Y Fertrin; Arthur Antolini; Fernando F Costa; Mônica B de Melo; Maria Laura Costa
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-28

Review 3.  Candidate Gene, Genome-Wide Association and Bioinformatic Studies in Pre-eclampsia: a Review.

Authors:  Semone Thakoordeen; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2018-08-29       Impact factor: 5.369

Review 4.  Maternal cholesterol levels during gestation: boon or bane for the offspring?

Authors:  V S Jayalekshmi; Surya Ramachandran
Journal:  Mol Cell Biochem       Date:  2020-09-22       Impact factor: 3.396

5.  Altered hippocampal arteriole structure and function in a rat model of preeclampsia: Potential role in impaired seizure-induced hyperemia.

Authors:  Abbie C Johnson; Marilyn J Cipolla
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis.

Authors:  Cassandra N Spracklen; Caitlin J Smith; Audrey F Saftlas; Jennifer G Robinson; Kelli K Ryckman
Journal:  Am J Epidemiol       Date:  2014-07-02       Impact factor: 4.897

Review 7.  Management of Hypercholesterolemia in Pregnant Women with Atherosclerotic Cardiovascular Disease.

Authors:  Aneesha Thobani; Lauren Hassen; Laxmi S Mehta; Anandita Agarwala
Journal:  Curr Atheroscler Rep       Date:  2021-08-04       Impact factor: 5.113

8.  Is the atherosclerotic phenotype of preeclamptic placentas due to altered lipoprotein concentrations and placental lipoprotein receptors? Role of a small-for-gestational-age phenotype.

Authors:  Marta R Hentschke; Carlos E Poli-de-Figueiredo; Bartira E Pinheiro da Costa; Lesia O Kurlak; Paula J Williams; Hiten D Mistry
Journal:  J Lipid Res       Date:  2013-07-29       Impact factor: 5.922

9.  Tracking and determinants of LDL particle size in healthy children from 7 to 11 years of age: the STRIP Study.

Authors:  Tuuli Kaitosaari; Olli Simell; Jorma Viikari; Olli Raitakari; Marja Siltala; Maarit Hakanen; Aila Leino; Eero Jokinen; Tapani Rönnemaa
Journal:  Eur J Pediatr       Date:  2008-07-05       Impact factor: 3.183

10.  Epidemiological analysis of maternal lipid levels during the second trimester in pregnancy and the risk of adverse pregnancy outcome adjusted by pregnancy BMI.

Authors:  Chao-Yan Yue; Chun-Mei Ying
Journal:  J Clin Lab Anal       Date:  2018-05-17       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.